• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒽醌、蒽酮及蒽醌衍生物对人巨细胞病毒的抗病毒活性评估。

Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.

作者信息

Barnard D L, Huffman J H, Morris J L, Wood S G, Hughes B G, Sidwell R W

机构信息

Utah State University, Logan.

出版信息

Antiviral Res. 1992 Jan;17(1):63-77. doi: 10.1016/0166-3542(92)90091-i.

DOI:10.1016/0166-3542(92)90091-i
PMID:1310583
Abstract

A number of anthraquinones, anthrones and anthraquinone derivatives were evaluated for antiviral activity against human cytomegalovirus (HCMV) as well as for cytotoxicity. Of those compounds evaluated, quinalizarin, emodin, rhein, hypericin, protohypericin, alizarin, emodin bianthrone and emodin anthrone showed antiviral activity against a normal laboratory HCMV strain, AD-169. When tested against a ganciclovir-resistant strain of HCMV, the EC50 values for quinalizarin, rhein and alizarin were superior to the values obtained for the AD-169 strain of HCMV. These results suggest that these compounds will be useful as prototypes for synthesizing a class of anti-HCMV drugs that are effective against ganciclovir-sensitive and -resistant strains of HCMV.

摘要

对多种蒽醌、蒽酮和蒽醌衍生物进行了抗人巨细胞病毒(HCMV)活性及细胞毒性评估。在所评估的这些化合物中,醌茜、大黄素、大黄酸、金丝桃素、原金丝桃素、茜素、大黄素双蒽酮和大黄素蒽酮对实验室常用的HCMV毒株AD-169显示出抗病毒活性。当针对耐更昔洛韦的HCMV毒株进行测试时,醌茜、大黄酸和茜素的EC50值优于针对HCMV的AD-169毒株所获得的值。这些结果表明,这些化合物将作为合成一类对HCMV的更昔洛韦敏感和耐药毒株均有效的抗HCMV药物的原型。

相似文献

1
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.蒽醌、蒽酮及蒽醌衍生物对人巨细胞病毒的抗病毒活性评估。
Antiviral Res. 1992 Jan;17(1):63-77. doi: 10.1016/0166-3542(92)90091-i.
2
Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives.磺化蒽醌和蒽醌衍生物的抗人巨细胞病毒活性及毒性
Antiviral Res. 1995 Dec;28(4):317-29. doi: 10.1016/0166-3542(95)00057-7.
3
In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives.所选蒽醌类化合物及蒽醌衍生物的体外杀病毒活性。
Antiviral Res. 1991 Sep;16(2):185-96. doi: 10.1016/0166-3542(91)90024-l.
4
Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.蒽醌类化合物阿他尼蓝PRL的抗巨细胞病毒活性。
Antiviral Res. 2015 Feb;114:86-95. doi: 10.1016/j.antiviral.2014.12.003. Epub 2014 Dec 10.
5
Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens.地衣中蒽醌、双蒽酮和金丝桃素衍生物的抗病毒活性。
Experientia. 1996 Feb 15;52(2):180-3. doi: 10.1007/BF01923366.
6
Synergistic effects of anthraquinones on the purgative activity of rhein anthrone in mice.蒽醌类化合物对小鼠大黄素蒽酮泻下活性的协同作用。
J Pharm Pharmacol. 1999 Jan;51(1):93-5.
7
An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.一种计算机设计的黄酮类衍生物,6-氟-4'-羟基-3',5'-二甲氧基黄酮,在感染细胞中比更昔洛韦具有更强的抗人巨细胞病毒作用。
Antiviral Res. 2018 Jun;154:10-16. doi: 10.1016/j.antiviral.2018.03.006. Epub 2018 Mar 17.
8
The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.青蒿琥酯是一种有效的人巨细胞病毒复制抑制剂。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00288-18. Print 2018 Jul.
9
Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives.非核苷类人巨细胞病毒抑制剂:(氯苯基甲基)苯并噻二嗪二氧化物衍生物的合成与抗病毒评价
J Med Chem. 2000 Aug 24;43(17):3267-73. doi: 10.1021/jm000118q.
10
Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.他汀类药物在体外对更昔洛韦敏感和耐药株均表现出广泛的抗巨细胞病毒活性。
J Med Virol. 2015 Jan;87(1):141-53. doi: 10.1002/jmv.23998. Epub 2014 Jun 27.

引用本文的文献

1
Natural products and derivatives as Japanese encephalitis virus antivirals.天然产物及其衍生物作为日本脑炎病毒抗病毒药物。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae022.
2
Construction of recombinant fluorescent LSDV for high-throughput screening of antiviral drugs.构建重组荧光 LSDV 用于高通量筛选抗病毒药物。
Vet Res. 2024 Mar 16;55(1):33. doi: 10.1186/s13567-024-01281-2.
3
Current Advances in Japanese Encephalitis Virus Drug Development.日本脑炎病毒药物研发的最新进展。
Viruses. 2024 Jan 28;16(2):202. doi: 10.3390/v16020202.
4
Identification of natural compounds as SARS-CoV-2 inhibitors molecular docking and molecular dynamic simulation.鉴定天然化合物作为新型冠状病毒 2 抑制剂:分子对接和分子动力学模拟
Front Microbiol. 2023 Feb 1;13:1095068. doi: 10.3389/fmicb.2022.1095068. eCollection 2022.
5
Comparative Analysis of the Efficiency of Medicinal Plants for the Treatment and Prevention of COVID-19.用于治疗和预防新冠肺炎的药用植物功效的比较分析
Int J Biomater. 2022 Dec 10;2022:5943649. doi: 10.1155/2022/5943649. eCollection 2022.
6
Influence of seasonal and geographic variation on the anti-HSV-1 properties and chlorogenic acids content of Sch. Bip.季节和地理变化对双花千里光抗单纯疱疹病毒1型特性及绿原酸含量的影响
Front Mol Biosci. 2022 Aug 25;9:961859. doi: 10.3389/fmolb.2022.961859. eCollection 2022.
7
Microbial Biosynthesis of Chrysazin Derivatives in Recombinant and Their Biological Activities.微生物生物合成重组菌中桑黄素衍生物及其生物活性。
Molecules. 2022 Aug 29;27(17):5554. doi: 10.3390/molecules27175554.
8
Promising Role of Emodin as Therapeutics to Against Viral Infections.大黄素作为抗病毒感染治疗药物的潜在作用。
Front Pharmacol. 2022 May 4;13:902626. doi: 10.3389/fphar.2022.902626. eCollection 2022.
9
Crystal structure, Hirshfeld surface and computational study of 1-(9,10-dioxo-9,10-di-hydroanthracen-1-yl)-3-propano-ylthio-urea.1-(9,10-二氧代-9,10-二氢蒽-1-基)-3-丙酰基硫脲的晶体结构、 Hirshfeld表面及计算研究
Acta Crystallogr E Crystallogr Commun. 2022 Mar 29;78(Pt 4):439-444. doi: 10.1107/S2056989022003127. eCollection 2022 Apr 1.
10
Preparation and Characterization of ACE2 Receptor Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce the Risk of COVID-19 Viral Infection.用于鼻腔制剂的载血管紧张素转换酶2(ACE2)受体抑制剂壳聚糖水凝胶的制备与表征,以降低新型冠状病毒肺炎(COVID-19)病毒感染风险
ACS Omega. 2022 Jan 14;7(4):3240-3253. doi: 10.1021/acsomega.1c05149. eCollection 2022 Feb 1.